First Trust Nasdaq Lux Digital Health… (EKG) Valuation
EKG valuation today
Holdings combined · company data as of Oct 26, 2026- P/E (TTM)
- 97.1 trailing earnings
- Forward P/E
- 29.7 analyst estimates
- Price / sales
- 4.38
- Price / book
- 5.93
- EV / EBITDA
- 23.3
- Earnings yield
- 1.03% inverse of P/E
- Dividend yield
- 0.07% of the holdings
- Return on equity
- 6.1% combined
- Net margin
- 4.5% combined
- Beta
- 1.47 weighted, vs S&P 500
EKG valuation vs other stock ETFs
| ETF | P/E | Fwd P/E | P/S | P/B | Div. yield | ROE | Net margin | Loss-makers |
|---|---|---|---|---|---|---|---|---|
| EKG | 97.1 | 29.7 | 4.38 | 5.93 | 0.07% | 6.1% | 4.5% | 32.2% |
| SPY | 25.9 | 19.9 | 3.67 | 5.47 | 1.08% | 21.1% | 14.2% | 1.9% |
| QQQ | 34.2 | 23.4 | 5.93 | 9.27 | 0.58% | 27.1% | 17.4% | 6.9% |
| DIA | 20.9 | 18.4 | 3.16 | 5.52 | 1.55% | 26.4% | 15.1% | 0.0% |
| VTI | 28.2 | 19.4 | 3.31 | 5.00 | 1.07% | 17.7% | 11.8% | 4.6% |
| IWM | n/m | 13.9 | 1.25 | 2.03 | 1.38% | −1.7% | −1.0% | 28.1% |
Same method for every fund. n/m = not meaningful (combined trailing earnings below zero or close to it). Loss-makers = weight of holdings with negative trailing earnings.
EKG valuation by sector
| Sector | Weight | P/E | Fwd P/E | P/S | P/B | Div. yield | ROE |
|---|---|---|---|---|---|---|---|
| Healthcare | 100.5% | 97.1 | 29.7 | 4.38 | 5.93 | 0.07% | 6.1% |
EKG earnings yield vs bond yields
Earnings yield = earnings ÷ price (1 ÷ P/E). The gap to bond yields is a rough gauge of the extra return stocks are priced to deliver.
How EKG weight splits by P/E
Share of the covered weight in companies with a trailing P/E in each range.
EKG largest holdings: valuation
| Symbol | Company | Weight | P/E | Fwd P/E | P/S | Div. yield | Share of earnings |
|---|---|---|---|---|---|---|---|
| NTRA | Natera, Inc. | 9.03% | — | — | 20.9 | — | −2.99% |
| ISRG | Intuitive Surgical, Inc. | 9.02% | 48.9 | 33.3 | 13.7 | — | 17.79% |
| VEEV | Veeva Systems Inc. | 8.64% | 50.9 | 30.2 | 14.5 | — | 16.40% |
| IQV | IQVIA Holdings Inc. | 7.98% | 33.2 | 18.4 | 2.6 | — | 23.24% |
| DXCM | DexCom, Inc. | 6.54% | 34.1 | 28.2 | 6.5 | — | 18.49% |
| ILMN | Illumina, Inc. | 4.52% | 49.0 | 40.3 | 8.8 | — | 8.90% |
| GH | Guardant Health, Inc. | 3.93% | — | — | 18.0 | — | −8.38% |
| RMD | ResMed Inc. | 3.71% | 22.9 | 18.5 | 5.9 | 1.10% | 15.64% |
| QGEN | Qiagen N.V. | 3.59% | 23.4 | 13.5 | 4.5 | 0.76% | 14.80% |
| GMED | Globus Medical, Inc. | 3.35% | 19.7 | 13.9 | 3.3 | — | 16.43% |
| PODD | Insulet Corporation | 3.12% | 26.4 | 54.9 | 3.2 | — | 11.42% |
| OSCR | Oscar Health, Inc. | 2.79% | 24.7 | 588.2 | 0.6 | — | 10.90% |
| ALGN | Align Technology, Inc. | 2.76% | 25.6 | 11.7 | 2.5 | — | 10.40% |
| TEM | Tempus AI, Inc. | 2.55% | — | — | 8.2 | — | −5.33% |
| HNGE | Hinge Health, Inc. | 2.21% | 32.7 | 33.0 | 11.1 | — | 6.52% |
| TWST | Twist Bioscience Corporation | 2.00% | — | — | 20.4 | — | −3.25% |
| HIMS | Hims & Hers Health, Inc. | 1.99% | — | 73.5 | 2.5 | — | −4.23% |
| TXG | 10x Genomics, Inc. | 1.89% | — | — | 14.8 | — | −1.42% |
| GRAL | GRAIL, Inc. | 1.85% | — | — | 31.8 | — | −14.69% |
| HTFL | Heartflow, Inc. | 1.27% | — | — | 19.8 | — | −0.61% |
| CAI | Caris Life Sciences, Inc. | 1.24% | 18.1 | 43.3 | 8.7 | — | 6.61% |
| DOCS | Doximity, Inc. | 1.19% | 36.4 | 19.8 | 8.4 | — | 3.16% |
| ADPT | Adaptive Biotechnologies Corporation | 1.18% | — | — | 12.4 | — | −1.95% |
| IRTC | iRhythm Technologies, Inc. | 1.08% | — | 90.9 | 4.3 | — | −0.40% |
| CDNA | CareDx, Inc | 1.07% | 30.8 | 156.2 | 7.2 | — | 3.36% |
Share of earnings = the holding's part of the fund's combined trailing profit. Green: earns more than its weight; orange: less. Symbol links go to each company's key metrics.
About EKG valuation
Adding up its 51 holdings with company data, EKG trades at 97.1 times trailing earnings and 29.7 times analysts' forward estimates, with a price-to-book ratio of 5.93 and a dividend yield of 0.07%. Its earnings yield of 1.03% is 4.30 percentage points below the 5.33% yield to maturity of the U.S. bond market (AGG).
The ten largest holdings are 60.3% of the fund and earn 120.3% of its combined profit. Companies that lost money over the past year are 32.2% of the covered weight.
How these figures are calculated. Each ratio treats the fund as one company: the earnings, sales and book value of every holding are added up in proportion to its weight and divided into the fund's price. In practice that is a weighted harmonic mean, so a single stock with a very high P/E cannot distort the result, and loss-making companies reduce the fund's earnings instead of being dropped. Covers 100.0% of the fund's weight (U.S.-listed stocks with company data); company figures as of October 26, 2026.
Related: EKG chart, EKG performance, EKG holdings.
EKG valuation FAQ
What is the P/E ratio of EKG?
Based on its holdings, EKG has a trailing P/E of 97.1 and a forward P/E of 29.7 (earnings of all covered holdings combined in proportion to their weights, as of October 26, 2026).
What is the earnings yield of EKG?
The trailing earnings yield is 1.03% (1 ÷ P/E) and the forward earnings yield 3.37%. For comparison the U.S. bond market (AGG) yields 5.33% to maturity and T-bills about 3.91%.
Is EKG more expensive than the S&P 500?
EKG trades at 97.1 times trailing earnings versus 25.9 for the S&P 500 (SPY); on forward estimates the figures are 29.7 and 19.9.
What is the price-to-book ratio of EKG?
The holdings of EKG trade at 5.93 times book value, with a combined return on equity of 6.1%.